학술논문
Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia
Document Type
Article
Author
Source
Blood Advances; 20230101, Issue: Preprints
Subject
Language
ISSN
24739529; 24739537
Abstract
•Knockdown of IGF2BP3 sensitizes MLL-AF4 leukemia to menin-MLL inhibition.•These data support the role of IGF2BP3 as an oncogenic amplifier in MLL-AF4 leukemogenesis and its therapeutic potential.